Basic and pleiotropic effects of vitamin D in patients with diabetes mellitus type 1 and 2

Main Article Content

I.V. Pankiv

Abstract

Vitamin D, being initially biologically inactive, turns into an active form in the body that interacts with the nuclear receptors of many tissues and organs. Because of this, today vitamin D is recognized as a D-hormone, although, following historical tradition, it continues to be called vitamin. The main role of vitamin D is reduced to the regulation of calcium homeostasis, which is largely due to the effect on the intestinal absorption of calcium ions and bone remodeling (formation and resorption). However, in recent decades at least 5 other areas of physiology have been identified in which vitamin D confidently shows its functions: innate immunity; adaptive immunity; insulin secretion in β-cells and other aspects of maintaining glucose homeostasis; heart function and blood pressure regulation; brain and fetal development. Our article deals with the third of these areas — the use of vitamin D for the prevention and treatment of type 1 and type 2 diabetes mellitus (DM-1 and DM-2). In experimental studies, it was demonstrated that vitamin D is important for adequate secretion of insulin and normalization of blood glucose levels. In clinical studies, a relationship has been established between low levels of vitamin D in serum and the risk of developing both types of diabetes mellitus. Vitamin D has been shown to be effective in the prevention and treatment of diabetes mellitus, although larger, longer, well-planned, randomized clinical trials are required. It is important that vitamin D exhibits additional pleiotropic effects found in patients with DM-2: it normalizes blood pressure, blood lipids, body mass index, fights chronic inflammation, and prevents the development of retinopathy and diabetic peripheral neuropathy. The administration of vitamin in high doses (2000–4000 IU/day or more) leads to the development of the desired effect in short-term treatment regimens (3–6 months). If the doctor is dealing with DM-1, the same high doses of vitamin A should be used.

Article Details

How to Cite
Pankiv, I. “Basic and Pleiotropic Effects of Vitamin D in Patients With Diabetes Mellitus Type 1 and 2”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 16, no. 1, Feb. 2020, pp. 50-57, doi:10.22141/2224-0721.16.1.2020.199128.
Section
Literature Review

References

Schwartz GYa. Vitamin D deficiency and its pharmacological correction. RMJ. 2009;(7):477-486. (in Russian).

Komba S, Kotake-Nara E, Tsuzuki W. Simultaneous Synthesis of Vitamins D2, D4, D5, D6, and D7 from Commercially Available Phytosterol, β-Sitosterol, and Identification of Each Vitamin D by HSQC NMR. Metabolites. 2019 Jun 6;9(6). pii: E107. doi: 10.3390/metabo9060107.

Vitamin D: Roles, Benefits, Forms, Serum Levels, Blood Tests. Available from: https://www.foodtips.org/vitamin-d-roles-benefits-forms-serum-levels-blood-tests/. Accessed: March 6, 2018.

Vitamin D. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/. Accessed: August 7, 2019.

Binkley N, Ramamurthy R, Krueger D. Low vitamin D status: definition, prevalence, consequences, and correction. Endocrinol Metab Clin North Am. 2010 Jun;39(2):287-301. doi: 10.1016/j.ecl.2010.02.008.

Medrano M, Carrillo-Cruz E, Montero I, Perez-Simon JA. Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications. Int J Mol Sci. 2018 Sep 8;19(9). pii: E2663. doi: 10.3390/ijms19092663.

Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008 Aug;88(2):491S-499S. doi: 10.1093/ajcn/88.2.491S.

Chakhtoura M, Azar ST. The role of vitamin d deficiency in the incidence, progression, and complications of type 1 diabetes mellitus. Int J Endocrinol. 2013;2013:148673. doi: 10.1155/2013/148673.

Muñoz-Garach A., García-Fontana B., Muñoz-Torres M. Vitamin D Status, Calcium Intake and Risk of Developing Type 2 Diabetes: An Unresolved Issue. Nutrients. 2019 Mar 16;11(3). pii: E642. doi: 10.3390/nu11030642.

Kadowaki S, Norman AW. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest. 1984 Mar;73(3):759-66. doi: 10.1172/JCI111269.

Jeddi S, Syedmoradi L, Bagheripour F, Ghasemi A. The effects of vitamin d on insulin release from isolated islets of rats. Int J Endocrinol Metab. 2015 Jan 30;13(1):e20620. doi: 10.5812/ijem.20620.

Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology. 1986 Jul;119(1):84-90. doi: 10.1210/endo-119-1-84.

Cade C, Norman AW. Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology. 1987 Apr;120(4):1490-7. doi: 10.1210/endo-120-4-1490.

Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 2003 Mar;17(3):509-11. doi: 10.1096/fj.02-0424fje.

Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008 Oct;29(6):726-76. doi: 10.1210/er.2008-0004.

Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013 May;36(5):1422-8. doi: 10.2337/dc12-0962.

Shen L, Zhuang QS, Ji HF. Assessment of vitamin D levels in type 1 and type 2 diabetes patients: Results from metaanalysis. Mol Nutr Food Res. 2016 May;60(5):1059-67. doi: 10.1002/mnfr.201500937.

Lucato P, Solmi M, Maggi S, et al. Low vitamin D levels increase the risk of type 2 diabetes in older adults: A systematic review and meta-analysis. Maturitas. 2017 Jun;100:8-15. doi: 10.1016/j.maturitas.2017.02.016.

Liu C, Lu M, Xia X, et al. Correlation of serum vitamin d level with type 1 diabetes mellitus in children: a meta-analysis. Nutr Hosp. 2015 Oct 1;32(4):1591-4. doi: 10.3305/nh.2015.32.4.9198.

Paschou SA, Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C. On type 1 diabetes mellitus pathogenesis. Endocr Connect. 2018 Jan;7(1):R38-R46. doi: 10.1530/EC-17-0347.

Harinarayan C.V. Vitamin D and diabetes mellitus. Hormones (Athens). 2014 Apr-Jun;13(2):163-81.

Cantorna MT, Snyder L, Lin YD, Yang L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 2015 Apr 22;7(4):3011-21. doi: 10.3390/nu7043011.

Zhang Z, Chen F, Li J, et al. 1,25(OH)2D3 suppresses proinflammatory responses by inhibiting Th1 cell differentiation and cytokine production through the JAK/STAT pathway. Am J Transl Res. 2018 Aug 15;10(8):2737-2746.

Imazeki I, Matsuzaki J, Tsuji K, Nishimura T. Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomed Res. 2006 Feb;27(1):1-9. doi: 10.2220/biomedres.27.1.

Verma R, Singh S, Singh B, et al. Role of Active Vitamin D3 in Immunity. Indian J Med Biochem. 2017;21(2):166-175. doi: 10.5005/jp-journals-10054-0043.

Gregoriou E, Mamais I, Tzanetakou I, Lavranos G, Chrysostomou S. The Effects of Vitamin D Supplementation in Newly Diagnosed Type 1 Diabetes Patients: Systematic Review of Randomized Controlled Trials. Rev Diabet Stud. 2017 Summer-Fall;14(2-3):260-268. doi: 10.1900/RDS.2017.14.260.

Hu Z, Chen J, Sun X, Wang L, Wang A. Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients: A meta-analysis of interventional studies. Medicine (Baltimore). 2019 Apr;98(14):e14970. doi: 10.1097/MD.0000000000014970.

Swart KM, Lips P, Brouwer IA, et al. Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2018 Jun 1;107(6):1043-1053. doi: 10.1093/ajcn/nqy078.

Li X, Liu Y, Zheng Y, Wang P, Zhang Y. The Effect of Vitamin D Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis. Nutrients. 2018 Mar 19;10(3). pii: E375. doi: 10.3390/nu10030375.

Santos RKF, Brandão-Lima PN, Tete RMDD, Freire ARS, Pires LV. Vitamin D ratio and glycaemic control in individuals with type 2 diabetes mellitus: A systematic review. Diabetes Metab Res Rev. 2018 Mar;34(3). doi: 10.1002/dmrr.2969.

Wu C, Qiu S, Zhu X, Li L. Vitamin D supplementation and glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. Metabolism. 2017 Aug;73:67-76. doi: 10.1016/j.metabol.2017.05.006.

Lee CJ, Iyer G, Liu Y, et al. The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: A systematic review and meta-analysis of intervention studies. J Diabetes Complications. 2017 Jul;31(7):1115-1126. doi: 10.1016/j.jdiacomp.2017.04.019.

Krul-Poel YH, Ter Wee MM, Lips P, Simsek S. MANAGEMENT OF ENDOCRINE DISEASE: The effect of vitamin D supplementation on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Eur J Endocrinol. 2017 Jan;176(1):R1-R14. doi: 10.1530/EJE-16-0391.

Nigil Haroon N, Anton A, John J, Mittal M. Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes: a systematic review of interventional studies. J Diabetes Metab Disord. 2015 Feb 12;14:3. doi: 10.1186/s40200-015-0130-9.

He S, Yu S, Zhou Z, Wang C, Wu Y, Li W. Effect of vitamin D supplementation on fasting plasma glucose, insulin resistance and prevention of type 2 diabetes mellitus in non-diabetics: A systematic review and meta-analysis. Biomed Rep. 2018 May;8(5):475-484. doi: 10.3892/br.2018.1074.

Lee KJ, Lee YJ. Effects of vitamin D on blood pressure in patients with type 2 diabetes mellitus. Int J Clin Pharmacol Ther. 2016 Apr;54(4):233-42. doi: 10.5414/CP202493.

Jafari T, Fallah AA, Rostampour N, Mahmoodnia L. Vitamin D ameliorates systolic but not diastolic blood pressure in patients with type 2 diabetes: Results from a meta-analysis of randomized controlled trials. Int J Vitam Nutr Res. 2018 Feb;88(1-2):90-99. doi: 10.1024/0300-9831/a000291.

Jafari T., Fallah A.A., Barani A. Effects of vitamin D on serum lipid profile in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Clin Nutr. 2016 Dec;35(6):1259-1268. doi: 10.1016/j.clnu.2016.03.001.

Rafiq S, Jeppesen PB. Body Mass Index, Vitamin D, and Type 2 Diabetes: A Systematic Review and Meta-Analysis. Nutrients. 2018 Aug 28;10(9). pii: E1182. doi: 10.3390/nu10091182.

Perna S. Is Vitamin D Supplementation Useful for Weight Loss Programs? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina (Kaunas). 2019 Jul 12;55(7). pii: E368. doi: 10.3390/medicina55070368.

Mousa A, Naderpoor N, Teede H, Scragg R, de Courten B. Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2018 May 1;76(5):380-394. doi: 10.1093/nutrit/nux077.

Yu Y, Tian L, Xiao Y, Huang G, Zhang M. Effect of Vitamin D Supplementation on Some Inflammatory Biomarkers in Type 2 Diabetes Mellitus Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ann Nutr Metab. 2018;73(1):62-73. doi: 10.1159/000490358.

Luo BA, Gao F, Qin L. The Association between Vitamin D Deficiency and Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis of Observational Studies. Nutrients. 2017 Mar 20;9(3). pii: E307. doi: 10.3390/nu9030307.

Juber SM. Evaluation Of Vitamin D Supplementation In Management Of Diabetic Retinopathy. IOSR Journal of Dental and Medical Sciences. 2018;17(3):1-45.

Smriti J, Chandra S, Lubhani J. A Study of Vitamin D Supplementation in Diabetic Retinopathy Patients with Type 2 Diabetes Mellitus. All India Ophthalmological Society Proceedings. 2017;FP435.

Qu GB, Wang LL, Tang X, Wu W, Sun YH. The association between vitamin D level and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: An update systematic review and meta-analysis. J Clin Transl Endocrinol. 2017 Jun 3;9:25-31. doi: 10.1016/j.jcte.2017.04.001.

Shehab D, Al-Jarallah K, Abdella N, Mojiminiyi OA, Al Mohamedy H. Prospective evaluation of the effect of short-term oral vitamin d supplementation on peripheral neuropathy in type 2 diabetes mellitus. Med Princ Pract. 2015;24(3):250-6. doi: 10.1159/000375304.

Ghadiri-Anari A, Mozafari Z, Gholami S, et al. Dose vitamin D supplementations improve peripheral diabetic neuropathy? A before-after clinical trial. Diabetes Metab Syndr. 2019 Jan - Feb;13(1):890-893. doi: 10.1016/j.dsx.2018.12.014.

Scott A, Chambers D, Goyder E, O'Cathain A. Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: A systematic review. PLoS One. 2017 May 10;12(5):e0177210. doi: 10.1371/journal.pone.0177210.

Bertoni AG, Krop JS, Anderson GF, Brancati FL. Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care. 2002 Mar;25(3):471-5. doi: 10.2337/diacare.25.3.471.